Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients.

Trilla-Fuertes L, Gámez-Pozo A, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, López-Vacas R, Nanni P, Zamora P, Espinosa E, Fresno Vara JÁ.

Future Oncol. 2019 Oct;15(30):3483-3490. doi: 10.2217/fon-2018-0698. Epub 2019 Oct 3.

PMID:
31580166
2.

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.

Bellet M, Ahmad F, Villanueva R, Valdivia C, Palomino-Doza J, Ruiz A, Gonzàlez X, Adrover E, Azaro A, Valls-Margarit M, Parra JL, Aguilar J, Vidal M, Martín A, Gavilá J, Escrivá-de-Romaní S, Perelló A, Hernando C, Lahuerta A, Zamora P, Reyes V, Alcalde M, Masanas H, Céliz P, Ruíz I, Gil M, Seguí MÀ, de la Peña L.

Ther Adv Med Oncol. 2019 May 10;11:1758835919833867. doi: 10.1177/1758835919833867. eCollection 2019. Review.

3.

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.

Sánchez-Rovira P, Zamora P, Salvador-Bofill J, Morales S, Martínez-Jáñez N, Martínez-de-Dueñas E, Lluch A, Illarramendi JJ, Gómez-Pardo P, Gavilá Gregori J, García-Palomo A, García-Mata J, Fernández Y, Del Barco S, de Juan A, Ciruelos E, Chacón JI, Calvo L, Barnadas A, Albanell J.

J Drug Assess. 2019 Apr 8;8(1):62-69. doi: 10.1080/21556660.2019.1604375. eCollection 2019.

4.

Function, Architecture, and Biogenesis of Reovirus Replication Neoorganelles.

Tenorio R, Fernández de Castro I, Knowlton JJ, Zamora PF, Sutherland DM, Risco C, Dermody TS.

Viruses. 2019 Mar 21;11(3). pii: E288. doi: 10.3390/v11030288. Review.

5.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Prado-Vázquez G, Gámez-Pozo A, Trilla-Fuertes L, Arevalillo JM, Zapater-Moros A, Ferrer-Gómez M, Díaz-Almirón M, López-Vacas R, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2019 Feb 7;9(1):1538. doi: 10.1038/s41598-018-38364-y.

6.

Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.

Ortega V, Antón A, Garau I, Afonso N, Calvo L, Fernández Y, Martínez-García M, Blanco E, Zamora P, García M, Illarramendi JJ, Rodríguez Sánchez CA, Sampayo M, Aguirre E, Pérez-García JM, Cortés J, Llombart-Cussac A.

Clin Breast Cancer. 2019 Apr;19(2):105-112. doi: 10.1016/j.clbc.2018.12.012. Epub 2018 Dec 20.

PMID:
30679100
7.

Epidemiology of Strongyloides stercoralis infection in Bolivian patients at high risk of complications.

Gétaz L, Castro R, Zamora P, Kramer M, Gareca N, Torrico-Espinoza MDC, Macias J, Lisarazu-Velásquez S, Rodriguez G, Valencia-Rivero C, Perneger T, Chappuis F.

PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0007028. doi: 10.1371/journal.pntd.0007028. eCollection 2019 Jan.

8.

Reovirus σNS and μNS Proteins Remodel the Endoplasmic Reticulum to Build Replication Neo-Organelles.

Tenorio R, Fernández de Castro I, Knowlton JJ, Zamora PF, Lee CH, Mainou BA, Dermody TS, Risco C.

MBio. 2018 Aug 7;9(4). pii: e01253-18. doi: 10.1128/mBio.01253-18.

9.

Nitrogen fixation in a landrace of maize is supported by a mucilage-associated diazotrophic microbiota.

Van Deynze A, Zamora P, Delaux PM, Heitmann C, Jayaraman D, Rajasekar S, Graham D, Maeda J, Gibson D, Schwartz KD, Berry AM, Bhatnagar S, Jospin G, Darling A, Jeannotte R, Lopez J, Weimer BC, Eisen JA, Shapiro HY, Ané JM, Bennett AB.

PLoS Biol. 2018 Aug 7;16(8):e2006352. doi: 10.1371/journal.pbio.2006352. eCollection 2018 Aug.

10.

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.

Zapater-Moros A, Gámez-Pozo A, Prado-Vázquez G, Trilla-Fuertes L, Arevalillo JM, Díaz-Almirón M, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jun 12;9(45):27586-27594. doi: 10.18632/oncotarget.25496. eCollection 2018 Jun 12.

11.

Reovirus Nonstructural Protein σNS Acts as an RNA Stability Factor Promoting Viral Genome Replication.

Zamora PF, Hu L, Knowlton JJ, Lahr RM, Moreno RA, Berman AJ, Prasad BVV, Dermody TS.

J Virol. 2018 Jul 17;92(15). pii: e00563-18. doi: 10.1128/JVI.00563-18. Print 2018 Aug 1.

12.

Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.

Barney CL, Walston S, Zamora P, Healy EH, Nolan N, Diavolitsis VM, Neki A, Rupert R, Savvides P, Agrawal A, Old M, Ozer E, Carrau R, Kang S, Rocco J, Teknos T, Grecula JC, Wobb J, Mitchell D, Blakaj D, Bhatt AD.

Oral Oncol. 2018 Apr;79:9-14. doi: 10.1016/j.oraloncology.2018.02.001. Epub 2018 Feb 12.

PMID:
29598954
13.

The TRiC chaperonin controls reovirus replication through outer-capsid folding.

Knowlton JJ, Fernández de Castro I, Ashbrook AW, Gestaut DR, Zamora PF, Bauer JA, Forrest JC, Frydman J, Risco C, Dermody TS.

Nat Microbiol. 2018 Apr;3(4):481-493. doi: 10.1038/s41564-018-0122-x. Epub 2018 Mar 12.

14.

Synchronous Supraglottic and Esophageal Squamous Cell Carcinomas Treated with a Monoisocentric Hybrid Intensity-Modulated Radiation Technique.

Barney CL, Zamora P, Ewing A, Old M, Chakravarti A, Bhatt A.

Front Oncol. 2018 Jan 8;7:307. doi: 10.3389/fonc.2017.00307. eCollection 2017.

15.

Allergic and non-allergic skin reactions associated with growth hormone therapy: elucidation of causative agents.

Mehta S, Oza V, Potashner R, Zamora P, Raisingani M, Shah B.

J Pediatr Endocrinol Metab. 2018 Jan 26;31(1):5-11. doi: 10.1515/jpem-2017-0309. Review.

PMID:
29197220
16.

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Peláez-García A, Yébenes L, Berjón A, Angulo A, Zamora P, Sánchez-Méndez JI, Espinosa E, Redondo A, Heredia-Soto V, Mendiola M, Feliú J, Hardisson D.

PLoS One. 2017 Sep 8;12(9):e0183452. doi: 10.1371/journal.pone.0183452. eCollection 2017.

17.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Gámez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, López-Vacas R, Díaz-Almirón M, Nanni P, Arevalillo JM, Navarro H, Grossmann J, Gayá Moreno F, Gómez Rioja R, Prado-Vázquez G, Zapater-Moros A, Main P, Feliú J, Martínez Del Prado P, Zamora P, Ciruelos E, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2017 Aug 30;7(1):10100. doi: 10.1038/s41598-017-10493-w.

18.

Orbital and conjunctival metastasis from lobular breast carcinoma.

Sánchez Orgaz M, Gonzalez Pessolani T, Pozo Kreilinger JJ, Zamora P, Martí Álvarez C, Boto-de-Los-Bueis A.

Orbit. 2017 Aug;36(4):197-200. doi: 10.1080/01676830.2017.1310255. Epub 2017 Apr 25.

PMID:
28441073
19.

Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.

Martínez-Jañez N, Chacón I, de Juan A, Cruz-Merino L, Del Barco S, Fernández I, García-Teijido P, Gómez-Bernal A, Plazaola A, Ponce J, Servitja S, Zamora P.

Breast Care (Basel). 2016 Apr;11(2):133-8. doi: 10.1159/000443601. Epub 2016 Feb 8.

20.

Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.

Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.

MBio. 2016 May 24;7(3). pii: e00693-16. doi: 10.1128/mBio.00693-16.

21.

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, Lush M, Milne RL, Shu XO, Beesley J, Kar S, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Zhao Z, Guo X, Benitez J, Beeghly-Fadiel A, Blot W, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broeks A, Brüning T, Burwinkel B, Cai H, Canisius S, Chang-Claude J, Choi JY, Couch FJ, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Droit A, Dork T, Fasching PA, Fletcher O, Flyger H, Fostira F, Gaborieau V, García-Closas M, Giles GG; Mervi Grip, Guenel P, Haiman CA, Hamann U, Hartman M, Miao H, Hollestelle A, Hopper JL, Hsiung CN; kConFab Investigators, Ito H, Jakubowska A, Johnson N, Torres D, Kabisch M, Kang D, Khan S, Knight JA, Kosma VM, Lambrechts D, Li J, Lindblom A, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Le Marchand L, Margolin S, Marme F, Matsuo K, McLean C, Meindl A, Muir K, Neuhausen SL, Nevanlinna H, Nord S, Børresen-Dale AL, Olson JE, Orr N, van den Ouweland AMW, Peterlongo P, Putti TC, Rudolph A, Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Shen CY, Hou MF, Shrubsole MJ, Southey MC, Swerdlow A, Teo SH, Thienpont B, Toland AE, Tollenaar RAEM, Tomlinson I, Truong T, Tseng CC, Wen W, Winqvist R, Wu AH, Yip CH, Zamora PM, Zheng Y, Floris G, Cheng CY, Hooning MJ, Martens JWM, Seynaeve C, Kristensen VN, Hall P, Pharoah PDP, Simard J, Chenevix-Trench G, Dunning AM, Antoniou AC, Easton DF, Cai Q, Long J.

Int J Cancer. 2016 Sep 15;139(6):1303-1317. doi: 10.1002/ijc.30150. Epub 2016 Jun 17.

22.

Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.

Mendiola M, Martínez-Marin V, Herranz J, Heredia V, Yébenes L, Zamora P, Castelo B, Pinto Á, Miguel M, Díaz E, Gámez A, Fresno JÁ, Ramírez de Molina A, Hardisson D, Espinosa E, Redondo A.

Oncotarget. 2016 Apr 26;7(17):24217-27. doi: 10.18632/oncotarget.8128.

23.

Protein markers of Bursaphelenchus xylophilus Steiner & Buhrer, 1934 (Nickle, 1970) populations using quantitative proteomics and character compatibility.

Ciordia S, Robertson L, Arcos SC, González MR, Mena Mdel C, Zamora P, Vieira P, Abrantes I, Mota M, Castagnone-Sereno P, Navas A.

Proteomics. 2016 Mar;16(6):1006-14. doi: 10.1002/pmic.201500106. Epub 2016 Feb 29.

PMID:
26718462
24.

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.

González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M.

Curr Cancer Drug Targets. 2016;16(5):415-28. Review.

PMID:
26278712
25.

[Health literacy in childhood and adolescence: An overview and current state of research].

Okan O, Pinheiro P, Zamora P, Bauer U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Sep;58(9):930-41. doi: 10.1007/s00103-015-2199-1. Review. German.

PMID:
26133161
26.

Multilocus genotyping of Amylostereum spp. associated with Sirex noctilio and other woodwasps from Europe reveal clonal lineage introduced to the US.

Castrillo LA, Hajek AE, Pajares JA, Thomsen IM, Csóka G, Kenaley SC, Kepler RM, Zamora P, Angeli S.

Fungal Biol. 2015 Jul;119(7):595-604. doi: 10.1016/j.funbio.2015.03.004. Epub 2015 Mar 14.

PMID:
26058535
27.

Measurement of pion, kaon and proton production in proton-proton collisions at [Formula: see text] TeV.

Adam J, Adamová D, Aggarwal MM, Rinella GA, Agnello M, Agrawal N, Ahammed Z, Ahmed I, Ahn SU, Aimo I, Aiola S, Ajaz M, Akindinov A, Alam SN, Aleksandrov D, Alessandro B, Alexandre D, Molina RA, Alici A, Alkin A, Alme J, Alt T, Altinpinar S, Altsybeev I, Prado CA, Andrei C, Andronic A, Anguelov V, Anielski J, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arcelli S, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Ball M, Pedrosa FB, Baral RC, Barbano AM, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartalini P, Bartke J, Bartsch E, Basile M, Bastid N, Basu S, Bathen B, Batigne G, Camejo AB, Batyunya B, Batzing PC, Bearden IG, Beck H, Bedda C, Behera NK, Belikov I, Bellini F, Martinez HB, Bellwied R, Belmont R, Belmont-Moreno E, Belyaev V, Bencedi G, Beole S, Berceanu I, Bercuci A, Berdnikov Y, Berenyi D, Bertens RA, Berzano D, Betev L, Bhasin A, Bhat IR, Bhati AK, Bhattacharjee B, Bhom J, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biswas S, Bjelogrlic S, Blanco F, Blau D, Blume C, Bock F, Bogdanov A, Bøggild H, Boldizsár L, Bombara M, Book J, Borel H, Borissov A, Borri M, Bossú F, Botje M, Botta E, Böttger S, Braun-Munzinger P, Bregant M, Breitner T, Broker TA, Browning TA, Broz M, Brucken EJ, Bruna E, Bruno GE, Budnikov D, Buesching H, Bufalino S, Buncic P, Busch O, Buthelezi Z, Buxton JT, Caffarri D, Cai X, Caines H, Diaz LC, Caliva A, Villar EC, Camerini P, Carena F, Carena W, Castellanos JC, Castro AJ, Casula EA, Cavicchioli C, Sanchez CC, Cepila J, Cerello P, Chang B, Chapeland S, Chartier M, Charvet JL, Chattopadhyay S, Chattopadhyay S, Chelnokov V, Cherney M, Cheshkov C, Cheynis B, Barroso VC, Chinellato DD, Chochula P, Choi K, Chojnacki M, Choudhury S, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Chung SU, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Colamaria F, Colella D, Collu A, Colocci M, Balbastre GC, Valle ZC, Connors ME, Contreras JG, Cormier TM, Morales YC, Maldonado IC, Cortese P, Cosentino MR, Costa F, Crochet P, Albino RC, Cuautle E, Cunqueiro L, Dahms T, Dainese A, Danu A, Das D, Das I, Das S, Dash A, Dash S, De S, Caro A, Cataldo G, Cuveland J, Falco A, Gruttola D, Marco N, Pasquale S, Deisting A, Deloff A, Dénes E, D'Erasmo G, Bari DD, Mauro AD, Nezza PD, Corchero MA, Dietel T, Dillenseger P, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Gimenez DD, Dönigus B, Dordic O, Dubey AK, Dubla A, Ducroux L, Dupieux P, Ehlers RJ, Elia D, Engel H, Erazmus B, Erhardt F, Eschweiler D, Espagnon B, Estienne M, Esumi S, Eum J, Evans D, Evdokimov S, Eyyubova G, Fabbietti L, Fabris D, Faivre J, Fantoni A, Fasel M, Feldkamp L, Felea D, Feliciello A, Feofilov G, Ferencei J, Téllez AF, Ferreiro EG, Ferretti A, Festanti A, Figiel J, Figueredo MA, Filchagin S, Finogeev D, Fionda FM, Fiore EM, Fleck MG, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Francescon A, Frankenfeld U, Fuchs U, Furget C, Furs A, Girard MF, Gaardhøje JJ, Gagliardi M, Gago AM, Gallio M, Gangadharan DR, Ganoti P, Gao C, Garabatos C, Garcia-Solis E, Gargiulo C, Gasik P, Germain M, Gheata A, Gheata M, Ghosh P, Ghosh SK, Gianotti P, Giubellino P, Giubilato P, Dziadus EG, Glässel P, Ramirez AG, Zamora PG, Gorbunov S, Görlich L, Gotovac S, Grabski V, Graczykowski LK, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerzoni B, Gulbrandsen K, Gulkanyan H, Gunji T, Gupta A, Gupta R, Haake R, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Hanratty LD, Hansen A, Harris JW, Hartmann H, Harton A, Hatzifotiadou D, Hayashi S, Heckel ST, Heide M, Helstrup H, Herghelegiu A, Corral GH, Hess BA, Hetland KF, Hilden TE, Hillemanns H, Hippolyte B, Hristov P, Huang M, Humanic TJ, Hussain N, Hussain T, Hutter D, Hwang DS, Ilkaev R, Ilkiv I, Inaba M, Ionita C, Ippolitov M, Irfan M, Ivanov M, Ivanov V, Izucheev V, Jacobs PM, Jahnke C, Jang HJ, Janik MA, Jayarathna PH, Jena C, Jena S, Bustamante RT, Jones PG, Jung H, Jusko A, Kalinak P, Kalweit A, Kamin J, Kang JH, Kaplin V, Kar S, Uysal AK, Karavichev O, Karavicheva T, Karpechev E, Kebschull U, Keidel R, Keijdener DL, Keil M, Khan KH, Khan MM, Khan P, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim B, Kim DW, Kim DJ, Kim H, Kim JS, Kim M, Kim M, Kim S, Kim T, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kiss G, Klay JL, Klein C, Klein J, Klein-Bösing C, Kluge A, Knichel ML, Knospe AG, Kobayashi T, Kobdaj C, Kofarago M, Köhler MK, Kollegger T, Kolojvari A, Kondratiev V, Kondratyeva N, Kondratyuk E, Konevskikh A, Kouzinopoulos C, Kovalenko O, Kovalenko V, Kowalski M, Kox S, Meethaleveedu GK, Kral J, Králik I, Kravčáková A, Krelina M, Kretz M, Krivda M, Krizek F, Kryshen E, Krzewicki M, Kubera AM, Kučera V, Kucheriaev Y, Kugathasan T, Kuhn C, Kuijer PG, Kulakov I, Kumar J, Kumar L, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kweon MJ, Kwon Y, Pointe SL, Rocca P, Fernandes CL, Lakomov I, Langoy R, Lara C, Lardeux A, Lattuca A, Laudi E, Lea R, Leardini L, Lee GR, Lee S, Legrand I, Lehnert J, Lemmon RC, Lenti V, Leogrande E, Monzón IL, Leoncino M, Lévai P, Li S, Li X, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Ljunggren HM, Lodato DF, Loenne PI, Loggins VR, Loginov V, Loizides C, Lopez X, Torres EL, Lowe A, Lu XG, Luettig P, Lunardon M, Luparello G, Maevskaya A, Mager M, Mahajan S, Mahmood SM, Maire A, Majka RD, Malaev M, Cervantes IM, Malinina L, Mal'Kevich D, Malzacher P, Mamonov A, Manceau L, Manko V, Manso F, Manzari V, Marchisone M, Mareš J, Margagliotti GV, Margotti A, Margutti J, Marín A, Markert C, Marquard M, Martin NA, Blanco JM, Martinengo P, Martínez MI, Martínez García G, Pedreira MM, Martynov Y, Mas A, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastroserio A, Masui H, Matyja A, Mayer C, Mazer J, Mazzoni MA, Mcdonald D, Meddi F, Menchaca-Rocha A, Meninno E, Pérez JM, Meres M, Miake Y, Mieskolainen MM, Mikhaylov K, Milano L, Milosevic J, Minervini LM, Mischke A, Mishra AN, Miśkowiec D, Mitra J, Mitu CM, Mohammadi N, Mohanty B, Molnar L, Zetina LM, Montes E, Morando M, Godoy DA, Moretto S, Morreale A, Morsch A, Muccifora V, Mudnic E, Mühlheim D, Muhuri S, Mukherjee M, Müller H, Mulligan JD, Munhoz MG, Murray S, Musa L, Musinsky J, Nandi BK, Nania R, Nappi E, Naru MU, Nattrass C, Nayak K, Nayak TK, Nazarenko S, Nedosekin A, Nellen L, Ng F, Nicassio M, Niculescu M, Niedziela J, Nielsen BS, Nikolaev S, Nikulin S, Nikulin V, Noferini F, Nomokonov P, Nooren G, Norman J, Nyanin A, Nystrand J, Oeschler H, Oh S, Oh SK, Ohlson A, Okatan A, Okubo T, Olah L, Oleniacz J, Silva AC, Oliver MH, Onderwaater J, Oppedisano C, Velasquez AO, Oskarsson A, Otwinowski J, Oyama K, Ozdemir M, Pachmayer Y, Pagano P, Paić G, Pajares C, Pal SK, Pan J, Pandey AK, Pant D, Papikyan V, Pappalardo GS, Pareek P, Park WJ, Parmar S, Passfeld A, Paticchio V, Paul B, Pawlak T, Peitzmann T, Costa HP, Filho EP, Peresunko D, Lara CE, Peskov V, Pestov Y, Petráček V, Petrov V, Petrovici M, Petta C, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Piyarathna DB, Płoskoń M, Planinic M, Pluta J, Pochybova S, Podesta-Lerma PL, Poghosyan MG, Polichtchouk B, Poljak N, Poonsawat W, Pop A, Porteboeuf-Houssais S, Porter J, Pospisil J, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puccio M, Puddu G, Pujahari P, Punin V, Putschke J, Qvigstad H, Rachevski A, Raha S, Rajput S, Rak J, Rakotozafindrabe A, Ramello L, Raniwala R, Raniwala S, Räsänen SS, Rascanu BT, Rathee D, Razazi V, Read KF, Real JS, Redlich K, Reed RJ, Rehman A, Reichelt P, Reicher M, Reidt F, Ren X, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Riabov V, Ricci RA, Richert T, Richter M, Riedler P, Riegler W, Riggi F, Ristea C, Rivetti A, Rocco E, Cahuantzi MR, Manso AR, Røed K, Rogochaya E, Rohr D, Röhrich D, Romita R, Ronchetti F, Ronflette L, Rosnet P, Rossi A, Roukoutakis F, Roy A, Roy C, Roy P, Montero AJ, Rui R, Russo R, Ryabinkin E, Ryabov Y, Rybicki A, Sadovsky S, Šafařík K, Sahlmuller B, Sahoo P, Sahoo R, Sahoo S, Sahu PK, Saini J, Sakai S, Saleh MA, Salgado CA, Salzwedel J, Sambyal S, Samsonov V, Castro XS, Šándor L, Sandoval A, Sano M, Santagati G, Sarkar D, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schuchmann S, Schukraft J, Schulc M, Schuster T, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott R, Seeder KS, Seger JE, Sekiguchi Y, Selyuzhenkov I, Senosi K, Seo J, Serradilla E, Sevcenco A, Shabanov A, Shabetai A, Shadura O, Shahoyan R, Shangaraev A, Sharma A, Sharma N, Shigaki K, Shtejer K, Sibiriak Y, Siddhanta S, Sielewicz KM, Siemiarczuk T, Silvermyr D, Silvestre C, Simatovic G, Simonetti G, Singaraju R, Singh R, Singha S, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Slupecki M, Smirnov N, Snellings RJ, Snellman TW, Søgaard C, Soltz R, Song J, Song M, Song Z, Soramel F, Sorensen S, Spacek M, Spiriti E, Sputowska I, Stassinaki MS, Srivastava BK, Stachel J, Stan I, Stefanek G, Steinpreis M, Stenlund E, Steyn G, Stiller JH, Stocco D, Strmen P, Suaide AA, Sugitate T, Suire C, Suleymanov M, Sultanov R, Šumbera M, Symons TJ, Szabo A, Toledo AS, Szarka I, Szczepankiewicz A, Szymanski M, Takahashi J, Tanaka N, Tangaro MA, Takaki JD, Peloni AT, Tariq M, Tarzila MG, Tauro A, Muñoz GT, Telesca A, Terasaki K, Terrevoli C, Teyssier B, Thäder J, Thomas D, Tieulent R, Timmins AR, Toia A, Trogolo S, Trubnikov V, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Tveter TS, Ullaland K, Uras A, Usai GL, Utrobicic A, Vajzer M, Vala M, Palomo LV, Vallero S, Maarel JV, Hoorne JW, Leeuwen MV, Vanat T, Vyvre PV, Varga D, Vargas A, Vargyas M, Varma R, Vasileiou M, Vasiliev A, Vauthier A, Vechernin V, Veen AM, Veldhoen M, Velure A, Venaruzzo M, Vercellin E, Limón SV, Vernet R, Verweij M, Vickovic L, Viesti G, Viinikainen J, Vilakazi Z, Baillie OV, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Vislavicius V, Viyogi YP, Vodopyanov A, Völkl MA, Voloshin K, Voloshin SA, Volpe G, Haller BV, Vorobyev I, Vranic D, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner J, Wang H, Wang M, Wang Y, Watanabe D, Weber M, Weber SG, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk G, Wilkinson J, Williams MC, Windelband B, Winn M, Yaldo CG, Yamaguchi Y, Yang H, Yang P, Yano S, Yasnopolskiy S, Yin Z, Yokoyama H, Yoo IK, Yurchenko V, Yushmanov I, Zaborowska A, Zaccolo V, Zaman A, Zampolli C, Zanoli HJ, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zgura IS, Zhalov M, Zhang H, Zhang X, Zhang Y, Zhao C, Zhigareva N, Zhou D, Zhou Y, Zhou Z, Zhu H, Zhu J, Zhu X, Zichichi A, Zimmermann A, Zimmermann MB, Zinovjev G, Zyzak M; ALICE Collaboration.

Eur Phys J C Part Fields. 2015;75(5):226. Epub 2015 May 27.

28.

Use of bevacizumab as a first-line treatment for metastatic breast cancer.

Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P.

Curr Oncol. 2015 Apr;22(2):e51-60. doi: 10.3747/co.22.2210.

29.

Prolonged response to aflibercept in ovarian cancer relapse: a case report.

Redondo A, Castelo B, Pinto A, Zamora P, Espinosa E.

Tumori. 2015 Mar 20;101(1):e29-31. doi: 10.5301/tj.5000202.

PMID:
25702661
30.

Correction for Fernández de Castro et al., Reovirus Forms Neo-Organelles for Progeny Particle Assembly within Reorganized Cell Membranes.

Fernández de Castro I, Zamora PF, Ooms L, Fernández JJ, Lai CM, Mainou BA, Dermody TS, Risco C.

MBio. 2015 Jan 27;6(1). pii: e02529-14. doi: 10.1128/mBio.02529-14. No abstract available.

31.

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

Martín M, Martínez N, Ramos M, Calvo L, Lluch A, Zamora P, Muñoz M, Carrasco E, Caballero R, García-Sáenz JÁ, Guerra E, Caronia D, Casado A, Ruíz-Borrego M, Hernando B, Chacón JI, De la Torre-Montero JC, Jimeno MÁ, Heras L, Alonso R, De la Haba J, Pita G, Constenla M, González-Neira A.

Oncologist. 2015 Feb;20(2):111-2. doi: 10.1634/theoncologist.2014-0379. Epub 2015 Jan 19.

32.

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer.

Redondo A, Martínez V, Zamora P, Castelo B, Pinto A, Cruz P, Higuera O, Mendiola M, Hardisson D, Espinosa E.

Onco Targets Ther. 2014 Nov 27;7:2175-81. doi: 10.2147/OTT.S70654. eCollection 2014.

33.

Evaluation of the degree of liver fibrosis and genetical characteristics in HIV patients with spontaneous clearance of HCV in Cartagena, Spain.

Méndez FJ, Almazán AJ, Nicolás CS, Vidal BA, Madrid OM, Encinas MA, García JG, Fernández LM, Zamora PC, Belmonte ER, Viñas PE, Santos JT.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19637. doi: 10.7448/IAS.17.4.19637. eCollection 2014.

34.

MicroRNA related polymorphisms and breast cancer risk.

Khan S, Greco D, Michailidou K, Milne RL, Muranen TA, Heikkinen T, Aaltonen K, Dennis J, Bolla MK, Liu J, Hall P, Irwanto A, Humphreys K, Li J, Czene K, Chang-Claude J, Hein R, Rudolph A, Seibold P, Flesch-Janys D, Fletcher O, Peto J, dos Santos Silva I, Johnson N, Gibson L, Aitken Z, Hopper JL, Tsimiklis H, Bui M, Makalic E, Schmidt DF, Southey MC, Apicella C, Stone J, Waisfisz Q, Meijers-Heijboer H, Adank MA, van der Luijt RB, Meindl A, Schmutzler RK, Müller-Myhsok B, Lichtner P, Turnbull C, Rahman N, Chanock SJ, Hunter DJ, Cox A, Cross SS, Reed MW, Schmidt MK, Broeks A, Van't Veer LJ, Hogervorst FB, Fasching PA, Schrauder MG, Ekici AB, Beckmann MW, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Benitez J, Zamora PM, Perez JI, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Pharoah PD, Dunning AM, Shah M, Luben R, Brown J, Couch FJ, Wang X, Vachon C, Olson JE, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Guénel P, Truong T, Laurent-Puig P, Mulot C, Marme F, Burwinkel B, Schneeweiss A, Sohn C, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Tchatchou S, Mulligan AM, Dörk T, Bogdanova NV, Antonenkova NN, Anton-Culver H, Darabi H, Eriksson M, Garcia-Closas M, Figueroa J, Lissowska J, Brinton L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Kristensen VN; kConFab Investigators; Australian Ovarian Cancer Study Group, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Lindblom A, Margolin S, Radice P, Peterlongo P, Barile M, Mariani P, Hooning MJ, Martens JW, Collée JM, Jager A, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Giles GG, McLean C, Brauch H, Brüning T, Ko YD; GENICA Network, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Kataja V, Kosma VM, Hartikainen JM, Mannermaa A, Hamann U, Chenevix-Trench G, Blomqvist C, Aittomäki K, Easton DF, Nevanlinna H.

PLoS One. 2014 Nov 12;9(11):e109973. doi: 10.1371/journal.pone.0109973. eCollection 2014.

35.

The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.

Gámez-Pozo A, Pérez Carrión RM, Manso L, Crespo C, Mendiola C, López-Vacas R, Berges-Soria J, López IÁ, Margeli M, Calero JL, Farre XG, Santaballa A, Ciruelos EM, Afonso R, Lao J, Catalán G, Gallego JV, López JM, Bofill FJ, Borrego MR, Espinosa E, Vara JA, Zamora P.

PLoS One. 2014 Oct 20;9(10):e109611. doi: 10.1371/journal.pone.0109611. eCollection 2014.

36.

Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study).

Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, Gómez P, Calvo L, Martinez P, Ruiz-Borrego M, Perelló A, Antón A, Codes M, Margelí M, Murias A, Salvador J, Seguí MÁ, de Juan A, Gavilá J, Luque M, Pérez D, Zamora P, Arizcuma A, Chacón JI, Heras L, Martin-Fernández M, Mahillo-Fernández I, Tusquets I.

Bone. 2014 Nov;68:32-40. doi: 10.1016/j.bone.2014.07.036. Epub 2014 Aug 7.

PMID:
25108081
37.

Leptospira-rat-human relationship in Luzon, Philippines.

Villanueva SY, Saito M, Baterna RA, Estrada CA, Rivera AK, Dato MC, Zamora PR, Segawa T, Cavinta LL, Fukui T, Masuzawa T, Yanagihara Y, Gloriani NG, Yoshida S.

Microbes Infect. 2014 Nov;16(11):902-10. doi: 10.1016/j.micinf.2014.07.001. Epub 2014 Jul 15.

PMID:
25048015
38.

9-fold Fresnel-Köhler concentrator with Fresnel lens of variable focal point.

Mendes-Lopes J, Benítez P, Zamora P, Miñano JC.

Opt Express. 2014 Jun 30;22 Suppl 4:A1153-63. doi: 10.1364/OE.22.0A1153.

PMID:
24978078
39.

Radical model of arsenic(III) toxicity: theoretical and EPR spin trapping studies.

Zamora PL, Rockenbauer A, Villamena FA.

Chem Res Toxicol. 2014 May 19;27(5):765-74. doi: 10.1021/tx4004227. Epub 2014 May 1.

PMID:
24754521
40.

Reovirus forms neo-organelles for progeny particle assembly within reorganized cell membranes.

Fernández de Castro I, Zamora PF, Ooms L, Fernández JJ, Lai CM, Mainou BA, Dermody TS, Risco C.

MBio. 2014 Feb 18;5(1). pii: e00931-13. doi: 10.1128/mBio.00931-13. Erratum in: MBio. 2015;6(1). pii: e02529-14. doi: 10.1128/mBio.02529-14.

41.

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, Meyer KB, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H, Kondo N; kConFab Investigators; Australian Ovarian Cancer Study Group, Hartman M, Hui M, Lim WY, Iau PT, Sawyer E, Tomlinson I, Kerin M, Miller N, Kang D, Choi J-, Park SK, Noh D-, Hopper JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay W-, Brauch H, Brüning T, Hamann U; GENICA Network, Dunning AM, Shah M, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Schmidt MK, Broeks A, Rosenberg EH, van't Veer LJ, Fasching PA, Renner SP, Ekici AB, Beckmann MW, Shen C-, Hsiung C-, Yu J-, Hou M-, Blot W, Cai Q, Wu AH, Tseng C-, Van Den Berg D, Stram DO, Cox A, Brock IW, Reed MW, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Shu X-, Lu W, Gao Y-, Zhang B, Radice P, Peterlongo P, Manoukian S, Mariette F, Sangrajrang S, McKay J, Couch FJ, Toland AE; TNBCC, Yannoukakos D, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Marme F, Burwinkel B, Guénel P, Truong T, Sanchez M, Mulot C, Bojesen SE, Nordestgaard BG, Flyer H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Mannermaa A, Kataja V, Kosma V-, Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Giles GG, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Simard J, Dumont M, Goldberg MS, Labréche F, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Devilee P, Tollenaar RA, Seynaeve C, García-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Czene K, Eriksson M, Humphreys K, Darabi H, Hooning MJ, Kriege M, Collée JM, Tilanus-Linthorst M, Li J, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova N, Dörk T, Hall P, Chenevix-Trench G, Easton DF, Pharroah PD, Arias-Perez JI, Zamora P, Benítez J, Milne RL.

Br J Cancer. 2014 Feb 18;110(4):1088-100. doi: 10.1038/bjc.2013.769.

42.

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Wang-Gohrke S, Steinemann D, Preisler-Adams S, Kast K, Varon-Mateeva R, Ellis S, Frost D, Platte R, Perkins J, Evans DG, Izatt L, Eeles R, Adlard J, Davidson R, Cole T, Scuvera G, Manoukian S, Bonanni B, Mariette F, Fortuzzi S, Viel A, Pasini B, Papi L, Varesco L, Balleine R, Nathanson KL, Domchek SM, Offitt K, Jakubowska A, Lindor N, Thomassen M, Jensen UB, Rantala J, Borg Å, Andrulis IL, Miron A, Hansen TV, Caldes T, Neuhausen SL, Toland AE, Nevanlinna H, Montagna M, Garber J, Godwin AK, Osorio A, Factor RE, Terry MB, Rebbeck TR, Karlan BY, Southey M, Rashid MU, Tung N, Pharoah PD, Blows FM, Dunning AM, Provenzano E, Hall P, Czene K, Schmidt MK, Broeks A, Cornelissen S, Verhoef S, Fasching PA, Beckmann MW, Ekici AB, Slamon DJ, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Flesch-Janys D, Rudolph A, Seibold P, Aittomäki K, Muranen TA, Heikkilä P, Blomqvist C, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Olson JE, Pankratz VS, John EM, Whittemore AS, West DW, Hamann U, Torres D, Ulmer HU, Rüdiger T, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Eccles DM, Tapper WJ, Durcan L, Jones L, Peto J, dos-Santos-Silva I, Fletcher O, Johnson N, Dwek M, Swann R, Bane AL, Glendon G, Mulligan AM, Giles GG, Milne RL, Baglietto L, McLean C, Carpenter J, Clarke C, Scott R, Brauch H, Brüning T, Ko YD, Cox A, Cross SS, Reed MW, Lubinski J, Jaworska-Bieniek K, Durda K, Gronwald J, Dörk T, Bogdanova N, Park-Simon TW, Hillemanns P, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Burwinkel B, Marme F, Surovy H, Yang R, Anton-Culver H, Ziogas A, Hooning MJ, Collée JM, Martens JW, Tilanus-Linthorst MM, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Lindblom A, Margolin S, Joseph V, Robson M, Rau-Murthy R, González-Neira A, Arias JI, Zamora P, Benítez J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Peterlongo P, Zaffaroni D, Barile M, Capra F, Radice P, Teo SH, Easton DF, Antoniou AC, Chenevix-Trench G, Goldgar DE; ABCTB Investigators; EMBRACE Group; GENICA Network; HEBON Group; kConFab Investigators.

Breast Cancer Res. 2014 Dec 23;16(6):3419. doi: 10.1186/s13058-014-0474-y.

43.

Free-form optics for Fresnel-lens-based photovoltaic concentrators.

Miñano JC, Benítez P, Zamora P, Buljan M, Mohedano R, Santamaría A.

Opt Express. 2013 May 6;21 Suppl 3:A494-502. doi: 10.1364/OE.21.00A494.

PMID:
24104438
44.

Reovirus cell entry requires functional microtubules.

Mainou BA, Zamora PF, Ashbrook AW, Dorset DC, Kim KS, Dermody TS.

MBio. 2013 Jul 2;4(4). pii: e00405-13. doi: 10.1128/mBio.00405-13.

45.

Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.

Zamora PL, Villamena FA.

Future Med Chem. 2013 Mar;5(4):465-78. doi: 10.4155/fmc.13.15. Review. Erratum in: Future Med Chem. 2013 Apr;5(6):734.

PMID:
23495692
46.

Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.

Zamora PO, Liu Y, Guo H, Lin X.

Int J Toxicol. 2013 Mar-Apr;32(2):154-61. doi: 10.1177/1091581813476960. Epub 2013 Feb 19.

PMID:
23422080
47.

Nonclinical assessment of tumor growth enhancement potential by B2A-coated ceramic granules used in arthodesis.

Zamora PO, Lin X, Liu Y, Guo H.

Int J Toxicol. 2013 Mar-Apr;32(2):146-53. doi: 10.1177/1091581813475488. Epub 2013 Feb 19.

PMID:
23422079
48.

Gene signatures in breast cancer: current and future uses.

Arranz EE, Vara JÁ, Gámez-Pozo A, Zamora P.

Transl Oncol. 2012 Dec;5(6):398-403. Epub 2012 Dec 1.

49.

B2A, a receptor modulator, increases the growth of pluripotent and preosteoblast cells through bone morphogenetic protein receptors.

Liu Y, Lin X, Takahashi K, Zamora PO.

Growth Factors. 2012 Dec;30(6):410-7. doi: 10.3109/08977194.2012.745520.

PMID:
23231667
50.

Supplemental Content

Loading ...
Support Center